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There is limited evidence that ginger (生薑 sheng jiang) powder consumption can relieve pain and
inﬂammation because of its special phytochemical properties. This study is aimed at investigating the
effect of ginger powder supplementation on some inﬂammatory markers in patients suffering from knee
osteoarthritis. This is a double-blind randomized placebo-controlled clinical trial with a follow-up period
of 3 months that was conducted on 120 outpatients with moderately painful knee osteoarthritis. Patients
were randomly divided up into two groups: ginger group (GG) or placebo group (PG). Both groups
received two identical capsules on a daily basis for 3 months. Each ginger capsule contained 500 mg of
ginger powder; the placebo capsules had 500 mg of starch in them. Serum samples were collected prior
to and after the intervention and were stored at 70 C until the end of the study. Serum concentration
of nitric oxide (NO) and hs-C reactive protein (hs-CRP) were measured using enzyme-linked immuno-
sorbent assay kits. There was no signiﬁcant difference between the two groups in terms of inﬂammatory
markers (i.e., NO and hs-CRP) prior to the intervention. However, after 3 months of supplementation,
serum concentration of NO and hs-CRP decreased in the GG. After 12 weeks, the concentration of these
markers declined more in the GG than in the PG. Ginger powder supplementation at a dose of 1 g/d can
reduce inﬂammatory markers in patients with knee osteoarthritis, and it thus can be recommended as a
suitable supplement for these patients.
Copyright © 2014, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Arthritis is a prevalent condition affecting millions of people
around the world.1 Osteoarthritis (OA) or degenerative arthritis is
the most common form of arthritis that is deﬁned by degeneration
of articular cartilage, joint pain and inﬂammation, and dysfunction
particularly in older people.2,3 Knee joints bear the largest part of
the body weight, and they are most likely to be at risk of OA.4 As the, Faculty of Health, Shahid
uare, Central Building, Yazd,
ffari-Khosravi).
for Food and Biomolecules,
molecules, National Taiwan Unive
ons.org/licenses/by-nc-nd/4.0/).prevalence of OA is high, and the nature of the disease is progres-
sive, it is not surprising that it has had an important effect on the
global economy.3,5 Factors that can predispose people to OA of the
knee are age, weight, bodymass index (BMI), genetics, occupational
activities, history of trauma, and physical work activities, especially
kneeling, squatting, lifting, and climbing.6e9
Treatment programs commonly involve nonpharmacological
and pharmacological measures. If pain becomes debilitating, joint
replacement surgery is to be used to ameliorate the quality of life.10
Generally, exercise and lifestyle modiﬁcation are considered non-
pharmacological measures,11 and analgesics are prescribed to
relieve pain. However, there is increasing concern that some an-
algesics may cause serious complications. For instance, some
cyclooxygenase-2 (COX-2) inhibitors such as nonsteroidal anti-
inﬂammatory drugs have been shown to increase the risk ofrsity. Production and hosting by Elsevier Taiwan LLC. This is an open access article
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ﬁndings of two in vitro studies demonstrated that naproxen,
indomethacin, and ibuprofen, which are the most frequently pre-
scribed nonsteroidal anti-inﬂammatory drugs, block the synthesis
of human cartilage matrix, and this is likely to increase the rate of
degeneration of articular cartilage in OA.13,14 This has led many
researchers to attempt to ﬁnd a remedy or modalities with negli-
gible side effects and signiﬁcant improvement in the symptoms.15
Ginger (生薑 sheng jiang) is an underground rhizome of the plant
Zingiber ofﬁcinale, belonging to the family Zingiberaceae, which is
one of the most popular herbs used in traditional medicine to
remedy diseases such as pregnancy-induced nausea and vomiting,
motion sickness, and arthritic conditions. It is thought that ginger
might be useful to human health owing to its anti-inﬂammatory
properties. The mechanism of its action is not clear, but it seems
to inhibit the activation of tumor necrosis factor-alpha (TNF-a),
interleukin-1b (IL-1b), and inducible nitric oxide synthase (iNOS).16
C-reactive protein (CRP) is a plasma protein that increases in the
systemic response to inﬂammatory events. Its rapid increase in
synthesis within hours after tissue injury or infection suggests that
it contributes to host defense and that it is part of the innate im-
mune response. There is an association between elevation of this
protein and future major cardiovascular events.17 Considering the
role of ginger in reducing inﬂammation and given the fact that we
could not ﬁnd any study in the literature on the long-term effects of
ginger on inﬂammation, this study was designed to determine the
effect of daily supplementation of 1 g ginger powder for 3 months
on inﬂammatory markers in older patients with knee OA.
2. Materials and methods
2.1. Study design and participants
This study was a double-blind randomized placebo-controlled
clinical trial, with a 3-month follow-up, of 120 patients with knee
OA visiting Khatam-ol-anbia Polyclinic in the city of Yazd in Iran.
This study was performed in the period spanning November 2011
to May 2012.
Criteria for inclusion were age (between 50 years and 70 years)
and diagnosis of OA veriﬁed by a rheumatologist according to the
classiﬁcation criteria of the American College of Rheumatology.18
Patients with any of the following were excluded: rheumatoid
arthritis, inﬂammatory diseases, metabolic disorders (such as dia-
betes, cancer, or other serious diseases), signs or history of liver or
kidney failure, treatment with oral corticosteroids within a period
of 4 weeks prior to the trial, corticosteroids injection within 6
months prior to the experiment, fever > 38C at screening, per-
manent consumption of ginger (生薑 sheng jiang), allergy to ginger,
unwillingness to continue the protocol, avoidance of consumption
of > 20% of the ginger supplements, any serious complications,
consumption of multivitamin, minerals, or other nutritional sup-
plements, and consumption of analgesic medications.
A total of 120 patients meeting the above-mentioned criteria
were randomly assigned to two groups (n ¼ participants each):
ginger group (GG) and placebo group (PG). Randomization was
done via tables of random numbers that were sequential list pre-
pared. The patients were asked to take two 500-mg capsules per
day for 3 months. The GG and PG capsules contained powdered
ginger and starch, respectively. Placebo and ginger capsules were
similar in terms of color, odor, weight, and packing. All the capsules
were manufactured in the Institute of Medicinal Plants in Tehran,
Iran. Patients were examined at the beginning of the study and then
again after 3 months in order to measure anthropometric indices.
Moreover, the participants ﬁlled out a researcher-made question-
naire with questions on age, occupation, education, and obesitystatus. The patients were asked not to change their normal diet. The
patients were also instructed to keep their daily use of the stairs to a
minimum. Furthermore, a rheumatologist taught them some kinds
of knee exercises.
2.2. Measurements
Anthropometric indices were obtained by a trained dietitian.
The patients' weights were measured using digital scales with a
readability of 0.1 kg and with the patients being minimally clothed,
without shoes. Height was measured using a stadiometer with a
readability of 0.5 cm and with the patients being in a standing
position without shoes. To determine the obesity status, the BMI
was calculated as weight (kg) divided by the square of height (m).
All anthropometric measurements were obtained on the same day
when blood specimens were taken.
2.3. Biochemical assessment
Both at the start of and 3 months after the experiment, 5 mL
peripheral blood was taken from each patient in a nonfasting state
through venipuncture of an antecubital vein (Suha, Iran). Serum
samples were stored at70C until the end of the study. Serum CRP
concentrations were measured using enzyme-linked immunosor-
bent assay kits (Biocore, Hamburg, Germany). Serum concentration
of nitric oxide was measured using a colorimetric assay kit
(Biocore).
2.4. Dietary assessment
Dietary intake was assessed by trained dietitians. Data on
24-hour recalls were collected from all 120 participants prior to and
after the intervention. The 24-hour recall is based on actual intake
and may be used to estimate absolute rather than relative intake.19
However, this method is susceptible to recall bias, both for identi-
ﬁcation of foods eaten and for quantiﬁcation of portion sizes. In
order to reduce this type of error in this study, dietary data were
collected by highly trained interviewers.20 Individuals were asked
whether the day of recalls was a usual day or not. To enter the data
into the computer, standard reference tables were used to convert
household portions to grams.21 After coding, the dietary recall form
was linked to a nutrient database (Nutritionist IV, Bruno, CA, USA).
For mixed dishes, food groups were calculated taking account of
their ingredients. The data related to Nutritionist IV were modiﬁed
in accordance with the Iranian Food Composition Table.
2.5. Ethical considerations
The protocol was explained to all patients. The participants
volunteered to participate in this study and had the possibility of
withdrawing from the study at any moment. The Ethics-in-
Research Commission of Shahid Sadoughi University of Medical
Sciences, Yazd, Iran approved the study, and all patients gave
written informed consent.
2.6. Statistical analysis
Data were submitted to SPSS 16.0.2 (2008; SPSS Inc., Chicago, IL,
USA).22 Prior to the statistical comparison, a KolmogoroveSmirnov
test was used to demonstrate the distribution of quantitative data.
Furthermore, the t test was used to draw a comparison between the
data obtained from the two groups (i.e., between-groups compar-
ison). In addition, Student t test was used for comparing the data
obtained from each group before and after the intervention (i.e.,
within-groups comparison). The results of the protocol are
Table 1
Comparison of baseline characteristics for the variables under investigation in
ginger and placebo groups.
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the quantitative data was normal. All analyses were performed at
the 0.05 level of signiﬁcance (2-tailed).Variables Ginger group
(n ¼ 50)
Placebo group
(n ¼ 50)
p
Age (y) 57.98 ± 6.2 59.1 ± 6.1 0.3
Weight (kg) 67.94 ± 7.0 66.3 ± 5.9 0.21
Height (cm) 161.4 ± 6.4 161.2 ± 7.0 0.9
BMI (kg/m2) 26.1 ± 2.9 25.5 ± 2.0 0.2
Sex
Men 3 (6) 7 (14) 0.31
Women 47 (94) 43 (86)
Obesity status
Obese 31 (62) 33 (66) 0.83
Nonobese 19 (38) 17 (34)
Education
Illiterate 20 (40) 18 (36) 0.60
Elementary school graduate 10 (20) 12 (24)
Middle and high school graduate 15 (30) 18 (36)
University graduate 5 (10) 2 (4)
Occupational status
Employed 18 (36) 20 (40) 0.40
Unemployed 32 (64) 30 (60)
Data are presented as n (%) or mean ± SD.
BMI ¼ body mass index.3. Results
At the beginning of the study,120 patients participated andwere
randomized. During the protocol, 20 patientsd10 receiving ginger
(生薑 sheng jiang) and 10 receiving placebodwere excluded: eight
of the participants withdrew because of a trip, eight due to loss of
follow-up, and four for undisclosed reasons. Therefore, 100 patients
completed the trial without protocol violations (Fig. 1).
Table 1 illustrates the baseline characteristics of the participants
prior to the intervention in both groups. As shown, the patients
were predominantly women, but the frequency of men andwomen
between groups was statistically insigniﬁcant (p¼ 0.83). There was
no signiﬁcant difference between the two groups in terms of age,
weight, height, and BMI. Similarly, the two groups were not
signiﬁcantly different in terms of sex, obesity, education, and
occupational status.
Table 2 presents the effect of ginger and starch on CRP and NO of
the patients at the beginning of and 3 months after the study. As
can be seen, there was no signiﬁcant difference between the two
groups in CRP and NO concentration prior to the intervention.
However, after supplementation of ginger, a signiﬁcant decrease
was observed in serum concentration of CRP and NO in the GG, but
not in the other group. At the end of the study, CRP and NOFig. 1. Study ﬂconcentration decreased more in the experimental group than in
the control group.
Table 2 also gives the means for some daily dietary intake in the
two groups prior to and after the intervention. No statisticallyowchart.
Table 2
Comparison ofmean of NO and CRP concentration in both ginger and placebo groups
prior to and after intervention.
Variables Ginger group Placebo group pa
Energy (kcal/d)
Prior to 1904.2 ± 325.4 1859.7 ± 272.2 0.6
After 2010.4 ± 401.0 1997.4 ± 213.1 0.3
pb 0.9 0.2
Fiber (g/d)
Prior to 9.2 ± 4.2 10.9 ± 9.9 0.5
After 12.3 ± 5.9 7.8 ± 8.2 0.9
p 0.8 0.6
Cholesterol (mg/d)
Prior to 302.02 ± 102.82 310.21 ± 123.02 0.08
After 295.02 ± 87.82 301.02 ± 95.12 0.6
p 0.7 0.5
NO (mmol/L)
Prior to 29.02 ± 0.82 29.21 ± 1.02 0.53
After 26.02 ± 1.82 27.02 ± 0.32 <0.001
Change 3.0 ± 0.72 2.01 ± 0.19 <0.001
p <0.001 <0.001
CRP (mg/L)
Prior to 11.06 ± 1.43 11.21 ± 1.20 0.56
After 8.47 ± 1.62 9.66 ± 1.31 <0.001
Change 2.58 ± 1.47 1.54 ± 1.12 <0.001
p <0.001 <0.001
CRP ¼ C-reactive protein; NO ¼ nitric oxide.
a Student t test.
b Paired t test.
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ﬁgures for daily energy and ﬁber and cholesterol intake. In other
words, between-group and within-group comparisons did not
show any signiﬁcant difference in daily energy and ﬁber and
cholesterol intake.4. Discussion
This study found that, in the patients who suffered from mod-
erate knee OA, the serum concentration of CRP and NO 3 months
after ginger (生薑 sheng jiang) supplementation was signiﬁcantly
different from the data obtained at the beginning of the study. This
ﬁnding is consistent with that of recent studies on ginger supple-
mentation on anti-inﬂammatory mediators. Lee et al23 found that
6-gingerol had an anti-inﬂammatory effect onmousemacrophages.
This active constituent of ginger decreased iNOS and TNF-a
expression by inhibiting I-kappaB alpha phosphorylation, nuclear
factor-kappa B (NF-kB) nuclear activation, and protein kinase C-
alpha translocation.
In another study, Jung et al24 showed that ginger hexane extract
(GHE) signiﬁcantly inhibited the excessive production of NO, pro-
tein, and mRNA expression of iNOS in lipopolysaccharide (LPS)-
stimulated BV-2 cells, a mouse microglial cell line, and attenuated
their gene expressions. Furthermore, GHE inhibited mRNA
expression and protein induction of COX-2 in BV-2 cells stimulated
through LPS. The only thing that was not affected by GHE was the
production of PGE2 or COX-2 expression in microglial cells. Also,
GHE signiﬁcantly suppressed the production of TNF-a and IL-1b
and reduced their gene expressions in these cells.24
In another in vitro study carried out by Shimoda et al25 to
evaluate the anti-inﬂammatory activity of red ginger extract (RGE),
Z. ofﬁcinale var. Rubra in mouse leukemic monocytes (RAW 264.7
cells) stimulated by LPS, it was found that RGE (100 mg/mL)
signiﬁcantly inhibited NO production. Moreover, dosage of 3 mg/mL
and 10 mg/mL signiﬁcantly inhibited PGE2 production. Separation
of RGE by means of bioassay showed that [6]-shogaol and ginger-
diols were capable of inhibiting NO production.25After 10 weeks of ginger supplementation and resistance
training, Atashak et al26 reported signiﬁcant decreases in the mean
values of CRP in three of the groups in their experiment: resistance
training plus ginger (RTGI), resistance training plus placebo (RTPL),
and ginger (GI). CRP concentration declined 35.1%, 28.3%, and 21.2%
in RTGI, RTPL, and GI groups, respectively.26
A recent study by Han et al27 found that treatment of Raw 264.7
cells, a murine macrophage-like cell line, with 150 ng/mL and
200 ng/mL of 12-dehydrogingerdione signiﬁcantly suppressed LPS-
stimulated production of NO. Moreover, this treatment suppressed
the LPS-stimulated increase in iNOS levels. However, treatment of
cells with LPS without 12-dehydrogingerdione signiﬁcantly
increased NO production.
In another study, daily supplementation of 2 g ginger for 2
months was found to signiﬁcantly decrease serum concentration of
hs-C reactive protein (hs-CRP), TNF- a, and IL-6 in the GG compared
with the baseline in type 2 diabetes patients.28 These factors did not
change in the PG during the protocol. In other words, covariance
analysis revealed that the level of hs-CRP and TNF- a lowered more
in the blood of the group receiving ginger than in the blood of the
placebo-receiving patients. However, the level of IL-6 remained
unchanged in both groups.
The results of the present research do not concur with the
ﬁndings of a few similar studies. Ueda et al22 studied the in vitro
effect of ginger extract on cytokines produced from a macrophage-
like cell line. After an oral administration of 100e1000 mg/mL
squeezed ginger extract (SGE) to mice, the production of TNF-a and
IL-6 and MCP-1 increased in mice cells. When the mice were orally
administered with the SGE or its ethanol-insoluble for a single time
or two, TNF-a production increased in peritoneal cells; however,
administration for more than four times had opposite results. In
addition, oral administration of the SGE for several times increased
immune resistance but caused an anti-inﬂammatory activity.
A possible mechanismwhereby ginger reduces inﬂammation in
patients with OA is as follows: activation of synovial cells in the
joints leads to the release of two key cytokines involved in the
inﬂammation and degradation of joints, TNF-a and IL-1b. Both
mediators induce NF-kB, which is a ubiquitous eukaryotic tran-
scription factor with a pivotal role in inﬂammatory pathways.29
This nuclear factor brings about inﬂammation by activating iNOS,
COX-2 pathway, and lipoxygenase pathway and by inducing the
secretion of inﬂammatory cytokines.
Ginger contains gingerols and shogaols, which are pungent
phenolic compounds with anti-inﬂammatory properties.30,31 These
substances decrease the two proinﬂammatory factors of TNF-a and
IL-1b in osteoarthritic cartilage. In synoviocytes, these compounds
decrease the IL-1b- or TNF-a-induced expression of TNF-a mRNA
and protein, the TNF-a-induced production of COX2, and the TNF-
a-induced activation of the NF-kB. In addition, these crucial com-
pounds suppress the synthesis of prostaglandin and leukotriene by
inhibiting the COX-2 and lipoxygenase pathways and also
inﬂammation-involved pathways.32,33 This way, they can diminish
the inﬂammation.
5. Conclusion
The present work is signiﬁcant in three ways. (1) We examined
the long-term effect of supplementation of ginger powder on in-
ﬂammatory markers in patients with knee OA. (2) The study was a
double-blind randomized clinical trial, meaning that neither the
researchers nor the patients were aware of the content of capsules.
(3) The protocol involved a control group that was similar to the GG
in all measurements.
It is also important to note the limitation in that the present study
did not measure neuronal sensitization, Immunoglobulin G (IgG),
Z. Naderi et al. / Journal of Traditional and Complementary Medicine 6 (2016) 199e203 203Immunoglobulin M (IgM), and did not determine ginger capsule's
formulation. Sample attrition resulting from patient withdrawal
may be regarded as another limitation of the protocol. Further
research into this topic could evaluate the effect of supplementation
of 1 g/d ginger capsule on lipid proﬁle, coagulation factors, other
inﬂammatory mediators, and neuronal sensitization. Future
research can also consider the effect of 1 g/d ginger capsule on
oxidative stress-related parameters.
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